Expression of the interleukin-6 gene is constitutive and not regulated by estrogen in rat vascular smooth muscle cells in culture

Citation
A. Maret et al., Expression of the interleukin-6 gene is constitutive and not regulated by estrogen in rat vascular smooth muscle cells in culture, ENDOCRINOL, 140(6), 1999, pp. 2876-2882
Citations number
60
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
ENDOCRINOLOGY
ISSN journal
00137227 → ACNP
Volume
140
Issue
6
Year of publication
1999
Pages
2876 - 2882
Database
ISI
SICI code
0013-7227(199906)140:6<2876:EOTIGI>2.0.ZU;2-Z
Abstract
Vascular smooth muscle cells (SMC) are major constituents of the medial lay er of blood vessels and are involved in the development of atherosclerotic plaque. SMC secrete copious IL-6 under basal conditions that can be increas ed by cytokines such as tumor necrosis factor-alpha and interleukin-1 beta (IL-1 beta). The goal of our studies was to define the role of estrogen in IL-6 production by SMC. In a first series of experiments, the expression of specific messenger RNAs as well as the production of IL-6 bioactivity by r at SMC in culture could be demonstrated in basal and IL-1-stimulated condit ions, but was unaffected by estrogen treatment. Different constructs contai ning deleted or mutated fragments of the human IL-6 promoter driving lucife rase or chloramphenicol acetyltransferase reporter gene were then transient ly transfected in these cells. A significant basal activity that was increa sed 2- to 4-fold after IL-1 beta stimulation was observed with the total IL -6 promoter. Deletion analysis indicated that the -158/+11 region containin g activator protein-1 and cAMP response element sites was apparently the mi nimal region of IL-6 promoter to confer both constitutive and IL-1-inducibl e activities. Site-directed mutagenesis experiments suggest that basal acti vity is dependent upon the promoter sequence -158 to -112 containing the nu clear factor (NF)-IL6(-153) and Sp1 sites, whereas IL-1 beta stimulation wo uld depend on the residual -112 nucleotides containing NF-IL6(-75) and NF-k appa B sites. in contrast to the down-regulation of IL-6 expression by estr ogen described in osteoblasts, ethinyl estradiol as well as 17 beta-estradi ol did not influence stimulated IL-6 activity in our experimental condition s whatever the construct tested, even when either estrogen receptor alpha o r beta was overexpressed. Thus, the atheroprotective properties of estrogen are probably not mediated through the regulation of IL-6 production by SMC .